GPT Healthcare Q4 FY26 Results: PAT Rs 14 Cr, Revenue Rs 140 Crore

GPT Healthcare Q4 FY26 results were declared on May 18, 2026, at the board of directors meeting. GPT Healthcare reported PAT of Rs 14 crore for the quarter ended March 31, 2026, up 17.0% YoY, on revenue of Rs 140 crore. GPT Healthcare operates in the multi-specialty hospital and healthcare services sector. Investors tracking GPT Healthcare Q4 FY26 will find complete financial analysis and FY27 outlook in this article.

Click Here – Get Free Investment Predictions

GPT Healthcare Q4 FY26 Financial Highlights

Metric	Q4 FY26	Comparison
PAT (Net Profit)	Rs 14 crore	up 17.0% YoY
Revenue from Operations	Rs 140 crore	Quarter ended March 31, 2026
Ticker		Sector: Healthcare

GPT Healthcare Q4 FY26 Performance Analysis

The firm reflects the company’s operational performance during the January to March 2026 quarter. GPT Healthcare is a leading multi-specialty hospital and healthcare services company whose Q4 FY26 print sets the baseline for FY27 guidance. The profitability improvement demonstrates effective operating leverage and cost management. Q4 January to March is typically a seasonally strong quarter for Indian companies driven by year-end government procurement and project completion cycles.

Investors tracking GPT will monitor FY27 revenue guidance, margin trajectory, and management commentary. Track GPT Healthcare on the Univest Screener for live data.

Check the Univest Screener for live data

Key Factors for the company

Revenue and Sector Dynamics

GPT revenue of Rs 140 crore reflects the company’s execution in the multi-specialty hospital and healthcare services space. India’s sustained economic growth of 6.5%+ and robust domestic demand across sectors provide a supportive backdrop for FY27 business planning.

Profitability and Margin Trends

The company PAT of Rs 14 crore up 17.0% YoY demonstrates consistent earnings delivery and improving profitability metrics. Management commentary on FY27 capex and growth investments will guide the stock’s near-term trajectory.

FY27 Business Outlook

Following the firm results, management guidance on FY27 revenue, order book, and strategic priorities will be key catalysts. Download the Univest iOS App or Univest Android App to receive SEBI-registered analyst research on GPT Healthcare.

Frequently Asked Questions on GPT

What is the company PAT?

Ans. GPT reported PAT of Rs 14 crore up 17.0% YoY. Results declared May 18, 2026. Full details from NSE/BSE regulatory filings. Verify all data before investing.

What is the company revenue?

Ans. The firm’s revenue from operations was Rs 140 crore for the quarter ended March 31, 2026. Track live on the Univest Screener.

When were GPT results announced?

Ans. The company results were announced on May 18, 2026, at the board meeting approving audited Q4 and FY26 financial statements for the year ended March 31, 2026.

Is GPT Healthcare a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, sector dynamics, and personal risk tolerance. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.